New Delhi, March 20 -- Emcure Pharmaceuticals, which is bringing Novo Nordisk's blockbuster semaglutide to India in an exclusive partnership, is banking on the perceived superiority and brand recognit... Read More
Mumbai, March 20 -- India's weight-loss drug market is on the verge of a price shake-up. In days, domestic drugmakers are set to launch cheaper versions of semaglutide, the GLP-1 (glucagon-like peptid... Read More
MUMBAI, March 20 -- Natco Pharma has heralded what could become an intense pricing war in India's pharmaceutical sector by offering its version of generic semaglutide that's 90% cheaper than the origi... Read More
New Delhi, March 19 -- India's weight-loss drug market is on the verge of a price shake-up. In days, domestic drugmakers are set to launch cheaper versions of semaglutide, the GLP-1 (glucagon-like pe... Read More
New Delhi, March 9 -- In a setback for Novo Nordisk, the Delhi High Court on Monday upheld an order permitting Dr. Reddy's Laboratories to manufacture diabetes and weight-loss drug semaglutide in Indi... Read More
New Delhi, Feb. 25 -- Ahmedabad-based drugmaker Zydus Lifesciences plans to launch its semaglutide injection brands upon patent expiry of the drug in India. The drugmaker said it will launch the drug ... Read More
Mumbai, Feb. 24 -- India's pharmaceutical companies, having conquered generics, must now pursue partnerships, collaborations and licensing deals to drive innovation at scale, industry executives said ... Read More
Mumbai, Feb. 24 -- Eris Lifesciences has tied up with Hyderabad-based Natco Pharma to commercialise semaglutide, ahead of the blockbuster weight-loss drug's patent expiry. The partnership comes on th... Read More
Mumbai, Feb. 14 -- Biocon Ltd is close to completing the integration of its subsidiary Biocon Biologics Ltd (BBL) with itself, after making progress last quarter on buying back the minority stake, Bio... Read More
Mumbai, Feb. 12 -- Early-stage healthcare-focused venture capital firm W Health Ventures is looking for bolder bets with its second fund, building companies from the ground up in areas like oncology, ... Read More